Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Grand Angels

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 26
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 19
Rounds per year 1.37
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.27
Exits 3
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Medical Device
  • Life Science
Summary

In 2004 was created Grand Angels, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Holland.

Among the most popular fund investment industries, there are Pharmaceutical, Life Science. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight HistoSonics, Ambiq Micro, AzulStar. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Grand Angels, startups are often financed by Wakestream Ventures, Venture Investors, Biosciences Research and Commercialization Center (BRCC). The meaningful sponsors for the fund in investment in the same round are Wakestream Ventures, Biosciences Research and Commercialization Center (BRCC), eLab Ventures. In the next rounds fund is usually obtained by Wakestream Ventures, eLab Ventures, Venture Investors.

The top activity for fund was in 2011. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this Corporate Investor is 3 percentage points less often commits exit comparing to other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Grand Angels:
Typical Co-investors
Grand Angels is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Grand Angels:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Avaloq Ventures Switzerland, Zürich, Zurich
Beijing Gaoxin Chengzhang Chuangtou Beijing, Beijing, China
Big Hit Music Seoul, Seoul-t'ukpyolsi, South Korea
Cresud Sacifya Argentina, Buenos Aires, Moreno
Dingxin Capital China, Guangdong, Shenzhen
Fonterra Co-operative Group Auckland, Auckland, New Zealand
Millry Communications Alabama, Millry, United States
Pacific Rim Partners California, San Francisco, United States
Signite Partners -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Akadeum Life Sciences

Biotechnology
Information Technology
Medical
$17M12 Oct 2021 Ann Arbor, Michigan, United States

ONL Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$46M22 Dec 2020 Ann Arbor, Michigan, United States

Ripple Science

Clinical Trials
Health Care
SaaS
Software
29 Sep 2020 Ann Arbor, Michigan, United States

Ripple Science

Clinical Trials
Health Care
SaaS
Software
01 Sep 2020 Ann Arbor, Michigan, United States

Ocuphire Pharma

Biopharma
Biotechnology
Pharmaceutical
$5M22 Jul 2019 Michigan, United States

Change Dynamix

Analytics
Security
Software
$2M01 Oct 2017 Royal Oak, Michigan, United States

HistoSonics

Health Care
Medical
Medical Device
Other Healthcare Technology Systems
Surgical Devices
$8M13 Mar 2017 Minnesota, United States

Tetra Therapeutics

Biotechnology
Therapeutics
$5M29 Nov 2016 Grand Rapids, Michigan, United States

Reconstruct

Computer Vision
Construction
Infrastructure
SaaS
$850K16 Sep 2016 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Grand Angels?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 26
Average round size 5M
Rounds per year 1.37
Peak activity year 2016
Lead investments 3
Follow on index 0.27
Exits 3
Group Appearance index 0.85

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Akadeum Life Sciences

Biotechnology
Information Technology
Medical
$17M12 Oct 2021 Ann Arbor, Michigan, United States

ONL Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$46M22 Dec 2020 Ann Arbor, Michigan, United States

Ripple Science

Clinical Trials
Health Care
SaaS
Software
29 Sep 2020 Ann Arbor, Michigan, United States

Ripple Science

Clinical Trials
Health Care
SaaS
Software
01 Sep 2020 Ann Arbor, Michigan, United States

Ocuphire Pharma

Biopharma
Biotechnology
Pharmaceutical
$5M22 Jul 2019 Michigan, United States

Change Dynamix

Analytics
Security
Software
$2M01 Oct 2017 Royal Oak, Michigan, United States

HistoSonics

Health Care
Medical
Medical Device
Other Healthcare Technology Systems
Surgical Devices
$8M13 Mar 2017 Minnesota, United States

Tetra Therapeutics

Biotechnology
Therapeutics
$5M29 Nov 2016 Grand Rapids, Michigan, United States

Reconstruct

Computer Vision
Construction
Infrastructure
SaaS
$850K16 Sep 2016 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: